Related Experiment Videos
T-cell lymphoma: morphology, immunophenotype and clinical features.
A S Krajewski1, M W Myskow, P G Cachia
1Department of Pathology, University of Edinburgh Medical School, Scotland.
Histopathology
|July 1, 1988
Summary
Aggressive chemotherapy improved complete response rates in T-cell lymphoma patients. Survival was significantly better for low/intermediate-grade lymphomas and earlier disease stages.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- T-cell lymphomas are a heterogeneous group of lymphoid malignancies.
- Accurate classification and understanding of prognostic factors are crucial for patient management.
Purpose of the Study:
- To describe the histology, immunophenotype, and clinical presentation of 43 T-cell lymphoma cases.
- To evaluate treatment responses and survival outcomes based on lymphoma subtype and clinical factors.
Main Methods:
- Histological and immunophenotypic analysis of tumor samples.
- Clinical data collection including staging, treatment, and follow-up.
- Life table analysis for survival probability assessment.
Main Results:
- Forty-three cases were classified into nine T-cell lymphoma subtypes.
- Aggressive therapy yielded a 48% complete response rate, compared to 7% with simple chemotherapy.
- Survival probability was significantly higher for low/intermediate-grade lymphomas and early-stage disease (I/II).
Conclusions:
- T-cell lymphoma classification impacts prognosis.
- Aggressive treatment strategies may improve response rates.
- Early diagnosis and treatment are associated with better survival outcomes.